Skip to content

Music and Symptom Relief in Radiotherapy Patient

Effects of Music on Pain, Anxiety and Stress Levels in Cancer Patients Receiving Radiotherapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06993441
Acronym
MUSİC
Enrollment
120
Registered
2025-05-28
Start date
2024-04-04
Completion date
2025-01-30
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Music Therapy

Brief summary

This randomized controlled study aims to evaluate the effects of music therapy administered during radiotherapy sessions on pain, stress, and anxiety levels in cancer patients. The intervention involves playing Musicure, a therapeutic music track, for 30 minutes via speakers during radiotherapy. The study includes two groups: an intervention group receiving music therapy and a control group receiving standard care without music. Participants' pain levels were assessed using the Visual Analog Scale (VAS), while anxiety and stress levels were measured using the Face Anxıety Subscale ( FAS). A total of 120 adult cancer patients undergoing outpatient radiotherapy at Tınaztepe Unıversty were included. The study was conducted under the supervision of Dr. Öğr. Üyesi \[Duygu AKBAŞ UYSAL (Principal Investigator) and co-researchers Prof.Dr Fsun ŞENUZUN AYKAR, Prof.Dr Zümra ARICAK ALICIKUŞ The research complies with ethical standards and has received approval from \[insert name of ethics committee\]. This study investigates a low-cost, non-pharmacological intervention that has the potential to improve symptom management and quality of life in cancer patients.

Interventions

Participants in the experimental group listened to MusICure music via speakers for 30 minutes during each radiotherapy session. The intervention was administered concurrently with radiotherapy and aimed to reduce anxiety and emotional distress.

BEHAVIORALcontrol group

No intervention

Sponsors

Ege University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Volunteer to participate in the study, * 18 years of age and older, * No hearing problems, * No communication and speech problems

Exclusion criteria

* Those diagnosed with psychiatric and neurological diseases,

Design outcomes

Primary

MeasureTime frameDescription
Pain LevelBaseline (before radiotherapy on Day 1) and immediately after the radiotherapy session on Day 1.Changes in pain levels were assessed using the Visual Analog Scale (VAS) immediately before and after a single radiotherapy session. The VAS score ranges from 0 (no pain) to 10 (worst possible pain).

Secondary

MeasureTime frameDescription
anxiety levelBaseline (before radiotherapy on Day 1) and immediately after the radiotherapy session on Day 1.Changes in anxiety levels were assessed using the Facial Anxiety Scale (FAS), a visual scale ranging from 0 (no anxiety) to 5 (severe anxiety), immediately before and after a single radiotherapy session.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026